1-7 of 7
Rebecca A. Gardner
Close
Sort by
Journal Articles

Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

Adam J. Lamble, Liora M. Schultz, Khanh Nguyen, Emily M. Hsieh, Kevin McNerney, Rayne H. Rouce, Rebecca A. Gardner, Sara Ghorashian, Nirali N. Shah, Shannon L. Maude
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3544–3548.
https://doi.org/10.1182/bloodadvances.2024013243
Published: 2024
Journal Articles

A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia

Katherine E. Masih, Rebecca A. Gardner, Hsien-Chao Chou, Abdalla Abdelmaksoud, Young K. Song, Luca Mariani, Vineela Gangalapudi, Berkley E. Gryder, Ashley L. Wilson, Serifat O. Adebola, Benjamin Z. Stanton, Chaoyu Wang, David Milewski, Yong Yean Kim, Meijie Tian, Adam Tai-Chi Cheuk, Xinyu Wen, Yue Zhang, Grégoire Altan-Bonnet, Michael C. Kelly, Jun S. Wei, Martha L. Bulyk, Michael C. Jensen, Rimas J. Orentas, Javed Khan
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4218–4232.
https://doi.org/10.1182/bloodadvances.2022008977
Published: 2023
Includes: Supplemental data
Journal Articles

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

Clinical Trials & Observations
Juliane Gust, Stephanie D. Rawlings-Rhea, Ashley L. Wilson, Niklas M. Tulberg, Amber L. Sherman, Kristy D. Seidel, Qian “Vicky” Wu, Julie R. Park, Rebecca A. Gardner, Colleen E. Annesley
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1001–1010.
https://doi.org/10.1182/bloodadvances.2022008119
Published: 2023
Includes: Supplemental data
Journal Articles

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Adam J. Lamble, Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg, Jennifer Sheppard, Alexandra E. Kovach, Brent Wood, Michael J. Borowitz, Maryalice Stetler-Stevenson, Constance M. Yuan, Vinodh Pillai, Toni Foley, Perry Chung, Lee Chen, Daniel W. Lee, Colleen Annesley, Amanda DiNofia, Stephan A. Grupp, Michael R. Verneris, Lia Gore, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca A. Gardner, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2023) 7 (4): 575–585.
https://doi.org/10.1182/bloodadvances.2022007423
Published: 2023
Includes: Supplemental data
Journal Articles

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

Emily M. Hsieh, Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M. Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W. Lee, Amanda DiNofia, Stephan A. Grupp, Michael R. Verneris, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca A. Gardner, Lia Gore, Nirali N. Shah, Adam J. Lamble
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5222–5226.
https://doi.org/10.1182/bloodadvances.2022008093
Published: 2022
Journal Articles

Anakinra utilization in refractory pediatric CAR T-cell associated toxicities

Caroline Diorio, Anant Vatsayan, Aimee C. Talleur, Colleen Annesley, Jennifer J. Jaroscak, Haneen Shalabi, Amanda K. Ombrello, Michelle Hudspeth, Shannon L. Maude, Rebecca A. Gardner, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3398–3403.
https://doi.org/10.1182/bloodadvances.2022006983
Published: 2022
Includes: Supplemental data
Journal Articles

Bilateral retinal detachment after chimeric antigen receptor T-cell therapy

Clinical Trials & Observations
Christopher C. Denton, William S. Gange, Hisham Abdel-Azim, Sonata Jodele, Neena Kapoor, Matthew J. Oberley, Kenneth Wong, Jonathan Kim, Abby Vercio, Parisah Moghaddampour, K. V. Chalam, David Sierpina, Rebecca A. Gardner, Michael A. Pulsipher, Michael C. Jensen, Aaron Nagiel
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2158–2162.
https://doi.org/10.1182/bloodadvances.2020001450
Published: 2020
Includes: Supplemental data